Nalaganje...
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis
Lenalidomide is associated with increased risk of thromboembolism (VTE) in patients with multiple myeloma. This risk has not previously been defined in B-cell non-Hodgkin lymphoma (NHL), for which lenalidomide is also an active agent. We conducted a systematic literature search in Ovid MEDLINE (1946...
Shranjeno v:
| izdano v: | Blood Adv |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020807/ https://ncbi.nlm.nih.gov/pubmed/29934343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016683 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|